The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat malignant hematological neoplasms and non-malignant hematological disorders. Approximately, 5000 allo-HSCT procedures are performed in China annually. Substantial progress has been made in haploidentical HSCT (HID...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lanping, Chen, Hu, Chen, Jing, Han, Mingzhe, Huang, He, Lai, Yongrong, Liu, Daihong, Liu, Qifa, Liu, Ting, Jiang, Ming, Ren, Hanyun, Song, Yongping, Sun, Zimin, Wang, Jianmin, Wu, Depei, Zhou, Daobin, Zou, Ping, Liu, Kaiyan, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833104/
https://www.ncbi.nlm.nih.gov/pubmed/29495966
http://dx.doi.org/10.1186/s13045-018-0564-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833104/
https://www.ncbi.nlm.nih.gov/pubmed/29495966
http://dx.doi.org/10.1186/s13045-018-0564-x

Ejemplares similares